Ossiam’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.26M Sell
5,957
-62
-1% -$13.4K 0.02% 203
2025
Q4
$1.24M Buy
6,019
+670
+13% +$126K 0.02% 194
2025
Q3
$840K Sell
5,349
-988
-16% -$153K 0.01% 502
2025
Q2
$1.06M Buy
6,337
+509
+9% +$75.5K 0.01% 377
2025
Q1
$803K Sell
5,828
-800
-12% -$102K 0.01% 371
2024
Q4
$784K Sell
6,628
-6,508
-50% -$760K 0.01% 383
2024
Q3
$1.45M Buy
13,136
+4,061
+45% +$425K 0.03% 276
2024
Q2
$892K Buy
9,075
+1,939
+27% +$198K 0.02% 376
2024
Q1
$799K Sell
7,136
-2,380
-25% -$257K 0.01% 424
2023
Q4
$959K Buy
9,516
+4,308
+83% +$427K 0.02% 367
2023
Q3
$452K Sell
5,208
-1,720
-25% -$155K 0.01% 487
2023
Q2
$655K Sell
6,928
-3,751
-35% -$317K 0.01% 387
2023
Q1
$806K Buy
10,679
+4,412
+70% +$333K 0.02% 322
2022
Q4
$482K Buy
6,267
+3,155
+101% +$240K 0.01% 370
2022
Q3
$208K Buy
+3,112
New +$197K 0.01% 442
2019
Q4
Sell
-7,877
Closed -$372K 481
2019
Q3
$372K Buy
+7,877
New +$360K 0.03% 261
2019
Q1
Sell
-209
Closed -$9K 284
2018
Q4
$9K Buy
+209
New +$10.9K ﹤0.01% 271

Other funds holding CAH

Ossiam's CAH Position: Q1 2026 in Review

Ossiam reduced its Cardinal Health (CAH) stake by 1% in Q1 2026, selling an estimated $13.4K and leaving 5,957 shares worth $1.26M. The position accounts for 0.02% of the portfolio, ranked #203.

Ossiam first reported a position in CAH in Q4 2018 and has held it in 17 quarters since. The position peaked at $1.45M in Q3 2024. 1,425 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Ossiam held 5,957 shares of Cardinal Health worth $1.26M as of Q1 2026.
  • Ossiam sold 62 Cardinal Health shares in Q1 2026, an estimated $13.4K.
  • Cardinal Health made up 0.02% of Ossiam's portfolio in Q1 2026, its #203 holding.
  • Ossiam first reported a position in Cardinal Health in Q4 2018 and has held it in 17 quarters since.
  • Ossiam's Cardinal Health position peaked at $1.45M in Q3 2024.
  • 1,425 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Ossiam's 13F filing for Q1 2026, filed 14 May 2026.